Earlier generations, including MZ-, JV-1-, and JMR-series antagonists, showed efficacy in endometrial 74 , renal 75 , lung 76,77,78 , glioblastoma 79 , breast 80 , and colon cancers 79
PMID:32708578
ADSCs cultured under normal conditions were used as controls
A: A common starting dose is 100200 mcg per injection, administered 23 times daily (often morning, post-workout, and before bed)
These are general references only appropriate dosing is highly individual and must be established by a licensed healthcare professional
Glossary of key terms Frequently asked questions Can you have too much B12